Study of Bailing Capsules with Guben Kechuan Granules to Treat Stable Bronchiectasis in Adults

What this Trial Is About

Researchers are evaluating whether the combination of Bailing Capsules and Guben Kechuan Granules can help treat adults with stable bronchiectasis. This study also aims to determine the safety of these combined treatments compared to the standard Western medical treatment. The main questions focus on whether this combination reduces the number of acute exacerbations in patients with stable bronchiectasis. Participants in the experimental group will take Bailing Capsules orally four capsules three times a day plus Guben Kechuan Granules one bag three times a day alongside standard Western medical treatment for 24 weeks. The control group will receive only the standard Western medical treatment. Both groups will be monitored throughout the study period, which includes visits at weeks 4, 12, 24, and 48, with symptom diaries kept by participants. During the study, participants will visit the clinic for checkups and tests to assess lung function at 12, 24, and 48 weeks. Researchers will measure the number of acute exacerbations during treatment and follow-up periods at 24 and 48 weeks. Safety and treatment adherence will be monitored throughout the trial, which lasts for nearly a year, allowing a comprehensive evaluation of treatment effects and patient health.

Clinical Study on the Treatment of Stable Bronchiectasis With Bailing Capsules Combined With Guben Kechuan Granules